Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting   tags : Biotech-beach    save search
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K twitter stocktwits trandingview |
Health Technology
 | | O: 0.25% H: 0.0% C: 0.0%
cell meeting therapeutics therapy
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Published: 2024-04-17 (Crawled : 23:00) - biospace.com/
ACAD | $16.82 -1.47% -1.49% 3.5M twitter stocktwits trandingview |
Health Technology
 | | O: 0.76% H: 0.0% C: 0.0%
neurology pharmaceuticals meeting
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.71% H: 0.0% C: 0.0%
drug preclinical meeting
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
LBPH | $17.48 -2.94% -3.03% 520K twitter stocktwits trandingview |
Manufacturing
 | | O: -0.61% H: 0.61% C: -7.83%
pharmaceuticals meeting study
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
NVNO | $4.65 -2.72% -2.8% 71K twitter stocktwits trandingview |
Manufacturing
 | | O: 2.96% H: 3.48% C: -9.7%
enous2024 positive topline meeting trial today
Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection
Published: 2024-02-21 (Crawled : 15:30) - biospace.com/
ENSC | News | $0.561 -3.31% -3.42% 190K twitter stocktwits trandingview |
Health Technology
 | | O: 1.07% H: 2.5% C: -3.12%
pf614 fda opioid meeting
City of Hope Scientists Present Promising New Research at American Society of Hematology Annual Meeting
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320 twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
hope city research meeting
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
Published: 2023-11-13 (Crawled : 17:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K twitter stocktwits trandingview |
Health Technology
 | | O: 0.08% H: 6.43% C: 0.81%
positive meeting study
Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio
Published: 2023-11-07 (Crawled : 16:00) - biospace.com/
ALGS | $0.735 -7.33% -7.9% 140K twitter stocktwits trandingview |
Health Technology
 | | O: 5.13% H: 0.13% C: -7.88%
meeting liver therapeutics
“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting
Published: 2023-11-06 (Crawled : 18:00) - biospace.com/
EOLS | $11.49 -0.61% -0.61% 350K twitter stocktwits trandingview |
Health Technology
 | | O: -0.13% H: 1.26% C: 0.63%
jeuveau meeting
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
Published: 2023-11-06 (Crawled : 14:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K twitter stocktwits trandingview |
Health Technology
 | | O: -4.0% H: 8.29% C: 3.13%
meeting study
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
Published: 2023-11-03 (Crawled : 18:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K twitter stocktwits trandingview |
Health Technology
 | | O: 1.77% H: 4.61% C: 3.65%
xmab research preclinical meeting
Final Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual Meeting
Published: 2023-10-25 (Crawled : 14:00) - biospace.com/
EOLS | $11.49 -0.61% -0.61% 350K twitter stocktwits trandingview |
Health Technology
 | | O: -0.63% H: 1.14% C: -1.27%
meeting phase 2
Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology
Published: 2023-10-19 (Crawled : 13:30) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K twitter stocktwits trandingview |
Health Technology
 | | O: 1.28% H: 0.0% C: -2.93%
presentation
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12Announces Plans to File IND Application in Neuropathic Pain
Published: 2023-09-07 (Crawled : 17:00) - biospace.com/
ARTL | $1.28 -1.94% 5.5K twitter stocktwits trandingview |
Health Technology
 | | O: 3.83% H: 22.13% C: -25.45%
art26 fda positive meeting application
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting
Published: 2023-09-06 (Crawled : 15:00) - biospace.com/
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
 | | O: 4.36% H: 4.18% C: -2.99%
cd19 international meeting
Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting
Published: 2023-07-25 (Crawled : 14:00) - biospace.com/
IMMX | $2.21 0.0% 64K twitter stocktwits trandingview |
| | O: -1.45% H: 5.15% C: 0.49%
nxc-201 presentation international meeting
Nexcella Completes Pre-IND Meeting with FDA on NXC-201 US Clinical Trial
Published: 2023-06-26 (Crawled : 18:00) - biospace.com/
IMMX | $2.21 0.0% 64K twitter stocktwits trandingview |
| | O: -2.3% H: 1.96% C: -4.71%
nxc-201 fda meeting trial
Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders
Published: 2023-06-01 (Crawled : 13:20) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K twitter stocktwits trandingview |
Health Technology
 | | O: 0.88% H: 1.97% C: -0.44%
meeting therapeutics
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
Published: 2023-05-18 (Crawled : 21:00) - biospace.com/
FLGT | $20.34 1.14% 1.13% 160K twitter stocktwits trandingview |
Health Services
 | | O: -0.81% H: 1.69% C: 0.51%
fid-007 presentation asco meeting
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.